Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
13 November 2025
Announcement INBRAIN Neuroelectronics, a leading brain-computer interface therapeutics (BCI-Tx) company establishing graphene-related neural technologies, has entered a smart partnership with the po...
13 November 2025
Announcement Ionis intends to form a supplemental page to further submit its potential by the end of the year to extend Tryngolza into an extreme hypertriglyceridemia. If accepted, then William Blai...
12 November 2025
Announcement Innate Pharma SA proudly declared that they have received clearance by the US Food and Drug Administration (FDA) for the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell ...
12 November 2025
Announcement The new generation of companies has been keeping an eye on the niche-sized hair loss market with fingers crossed for the best new scientific focus and formulations to discover treatment...
12 November 2025
Announcement Hinge Health (HNGE), a leading digital health company offering personalised programs to help individuals deal with musculoskeletal (MSK) pain via virtual care, lifestyle support and exe...
12 November 2025
Announcement Eli Lilly has agreed with the legal body, the US government and has entered an agreement to extend its reach to its obesity treatments for self-pay patients and Medicare beneficiaries. T...
11 November 2025
Announcement The major IAVI’s Lassa virus (LASV) vaccine candidate findings from a first-in-human, Phase 1 clinical trial are now on the page of New England Journal of Medicine. The published ...
11 November 2025
Announcement GeneDx, a captain of improved health outcomes, shores delivering excellence via genomic insights, has hinted that it will soon reveal the research findings at a time of four major sessio...
11 November 2025
Announcement Eli Lilly’s amylin agonist, eloralintide, successfully showed 20% of weight loss in its mid-stage study that marked the course for the phase 3 trial. The analyst, William Blair, c...
11 November 2025
Announcement Novo Nordisk and Eli Lilly will provide their GLP-1 drugs via President Donald Trump’s direct-to-consumer marketplace for worth $350 per month. The future pills manufactured by in...
Speak with a healthcare analyst about your research, consulting, or platform needs.